{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,4]],"date-time":"2026-06-04T19:34:07Z","timestamp":1780601647896,"version":"3.54.1"},"reference-count":27,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,1,7]],"date-time":"2026-01-07T00:00:00Z","timestamp":1767744000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,2,4]],"date-time":"2026-02-04T00:00:00Z","timestamp":1770163200000},"content-version":"vor","delay-in-days":28,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Gastroenterol"],"DOI":"10.1186\/s12876-025-04516-4","type":"journal-article","created":{"date-parts":[[2026,1,7]],"date-time":"2026-01-07T07:06:45Z","timestamp":1767769605000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["The effect of the use of proton pump inhibitors (PPI) on complications in patients with cirrhosis"],"prefix":"10.1186","volume":"26","author":[{"given":"Halil","family":"Atasoy","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arzu","family":"Levent","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,1,7]]},"reference":[{"issue":"9615","key":"4516_CR1","doi-asserted-by":"publisher","first-page":"838","DOI":"10.1016\/S0140-6736(08)60383-9","volume":"8","author":"D Schuppan","year":"2008","unstructured":"Schuppan D, Afdhal NH. Liver cirrhosis. Lancet. 2008;8(9615):838\u201351. https:\/\/doi.org\/10.1016\/S0140-6736(08)60383-9.","journal-title":"Lancet"},{"key":"4516_CR2","doi-asserted-by":"publisher","first-page":"1749","DOI":"10.1016\/S0140-6736(14)60121-5","volume":"383","author":"EA Tsochatzis","year":"2014","unstructured":"Tsochatzis EA, Bosch J, Burroughs AK. Liver cirrhosis. Lancet. 2014;383:1749\u201361.","journal-title":"Lancet"},{"key":"4516_CR3","doi-asserted-by":"publisher","unstructured":"Yoon YH, Chen CM. Surveillance Report 111: Liver Cirrhosis Mortality in the United States: National, State, and Regional Trends, 2000\u20132015. 2018. https:\/\/doi.org\/10.13140\/RG.2.2.19487.46241.","DOI":"10.13140\/RG.2.2.19487.46241"},{"key":"4516_CR4","doi-asserted-by":"publisher","first-page":"702","DOI":"10.3109\/00365521.2012.661759","volume":"47","author":"A Dam Fialla","year":"2012","unstructured":"Dam Fialla A, Schaffalitzky de Muckadell OB, Touborg Lassen A. Incidence, etiology and mortality of cirrhosis: a population-based cohort study. Scand J Gastroenterol. 2012;47:702\u20139.","journal-title":"Scand J Gastroenterol"},{"key":"4516_CR5","doi-asserted-by":"publisher","first-page":"593","DOI":"10.1016\/j.jhep.2012.12.005","volume":"58","author":"M Blachier","year":"2013","unstructured":"Blachier M, Leleu H, Peck RM, Valla DC, Thoraval FR. The burden of liver disease in europe: a review of available epidemiological data. J Hepatol. 2013;58:593\u2013608.","journal-title":"J Hepatol"},{"key":"4516_CR6","first-page":"85","volume":"110","author":"J Wiegand","year":"2013","unstructured":"Wiegand J, Berg T. The etiology, diagnosis and prevention of liver cirrhosis. Dtsch Arztebl Int. 2013;110:85\u201391.","journal-title":"Dtsch Arztebl Int"},{"key":"4516_CR7","volume-title":"Cirrhosis in adults: Etiologies, clinical manifestations and diagnosis","author":"E Goldberg","year":"2015","unstructured":"Goldberg E, Chopra S. Cirrhosis in adults: Etiologies, clinical manifestations and diagnosis. Waltham, MA: UpToDate; 2015."},{"issue":"1","key":"4516_CR8","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1146\/annurev.pa.35.040195.001425","volume":"35","author":"G Sachs","year":"1995","unstructured":"Sachs G, Shin JM, Briving C, Wallmark B, Hersey S. Toxicology. The Pharmacology of the gastric acid pump: the H+, K\u2009+\u2009ATPase. Annu Rev Pharmacol Toxicol. 1995;35(1):277\u2013305.","journal-title":"Annu Rev Pharmacol Toxicol"},{"issue":"1","key":"4516_CR9","doi-asserted-by":"publisher","first-page":"27","DOI":"10.5009\/gnl15502","volume":"11","author":"DS Strand","year":"2017","unstructured":"Strand DS, Kim D, Peura DA. 25 years of proton pump inhibitors: a comprehensive review. Gut Liver. 2017;11(1):27\u201337.","journal-title":"Gut Liver"},{"key":"4516_CR10","doi-asserted-by":"publisher","DOI":"10.1177\/2042098618809927","volume":"10","author":"M Jaynes","year":"2019","unstructured":"Jaynes M, Kumar AB. The risks of long-term use of proton pump inhibitors: a critical review. Ther Adv Drug Saf. 2019;10:2042098618809927.","journal-title":"Ther Adv Drug Saf"},{"issue":"9","key":"4516_CR11","doi-asserted-by":"publisher","first-page":"769","DOI":"10.2165\/00002018-200629090-00002","volume":"29","author":"H Blume","year":"2006","unstructured":"Blume H, Donath F, Warnke A, Schug BS. Pharmacokinetic drug interaction profiles of proton pump inhibitors. Drug Saf. 2006;29(9):769\u201384.","journal-title":"Drug Saf"},{"issue":"9","key":"4516_CR12","first-page":"595","volume":"57","author":"U Fuhr","year":"2002","unstructured":"Fuhr U, Jetter A. Rabeprazole: Pharmacokinetics and Pharmacokinetic drug interactions. Pharmazie. 2002;57(9):595\u2013601 PMID: 12369444.","journal-title":"Pharmazie."},{"issue":"2","key":"4516_CR13","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1177\/1060028014559244","volume":"49","author":"EA Lo","year":"2015","unstructured":"Lo EA, Wilby KJ, Ensom MH. Use of proton pump inhibitors in the management of gastroesophageal varices: a systematic review. Ann Pharmacother. 2015;49(2):207\u201319. https:\/\/doi.org\/10.1177\/1060028014559244.","journal-title":"Ann Pharmacother"},{"key":"4516_CR14","doi-asserted-by":"publisher","DOI":"10.21037\/amj.2017.03.04","volume":"2","author":"J Zhu","year":"2017","unstructured":"Zhu J, Yu H, Mancuso A, Qi X. Proton pump inhibitors in liver cirrhosis: a review of benefits and harms. AME Med J. 2017;2:36.","journal-title":"AME Med J"},{"key":"4516_CR15","doi-asserted-by":"publisher","first-page":"e110503","DOI":"10.1371\/journal.pone.0110503","volume":"9","author":"M Mandorfer","year":"2014","unstructured":"Mandorfer M, Bota S, Schwabl P, Bucsics T, Pfisterer N, Summereder C, et al. Proton pump inhibitor intake neither predisposes to spontaneous bacterial peritonitis or other infections nor increases mortality in patients with cirrhosis and ascites. PLoS One. 2014;9:e110503.","journal-title":"PLoS One"},{"key":"4516_CR16","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1111\/apt.13061","volume":"41","author":"G Dultz","year":"2015","unstructured":"Dultz G, Piiper A, Zeuzem S, Kronenberger B, Waidmann O. Proton pump inhibitor treatment is associated with the severity of liver disease and increased mortality in patients with cirrhosis. Aliment Pharmacol Ther. 2015;41:459\u201366.","journal-title":"Aliment Pharmacol Ther"},{"key":"4516_CR17","first-page":"j406","volume":"69","author":"European Association for the Study of the Liver","year":"2018","unstructured":"European Association for the Study of the Liver. EASL Clinical Practice Guidelines for the management of patients with decompensated cirrhosis. Clinical Practice Guidelines J Hepatol. 2018;69:j406-460.","journal-title":"Clinical Practice Guidelines. J Hepatol."},{"key":"4516_CR18","doi-asserted-by":"publisher","first-page":"1130","DOI":"10.1038\/ajg.2009.80","volume":"104","author":"JS Bajaj","year":"2009","unstructured":"Bajaj JS, Zadvornova Y, Heuman DM, Hafeezullah M, Hoffmann RG, Sanyal AJ, et al. Association of proton pump inhibitor therapy with spontaneous bacterial peritonitis in cirrhotic patients with ascites. Am J Gastroenterol. 2009;104:1130\u20134.","journal-title":"Am J Gastroenterol"},{"key":"4516_CR19","doi-asserted-by":"publisher","first-page":"866","DOI":"10.1111\/apt.12045","volume":"36","author":"JS Bajaj","year":"2012","unstructured":"Bajaj JS, Ratliff SM, Heuman DM, Lapane KL. Proton pump inhibitors are associated with a high rate of serious infections in veterans with decompensated cirrhosis. Aliment Pharmacol Ther. 2012;36:866\u201374.","journal-title":"Aliment Pharmacol Ther"},{"issue":"33","key":"4516_CR20","doi-asserted-by":"publisher","first-page":"4933","DOI":"10.3748\/wjg.v25.i33.4933","volume":"25","author":"MA De Roza","year":"2019","unstructured":"De Roza MA, Kai L, Kam JW, Chan YH, Kwek A, Ang TL, et al. Proton pump inhibitor use increases mortality and hepatic decompensation in liver cirrhosis. World J Gastroenterol. 2019;25(33):4933\u201344.","journal-title":"World J Gastroenterol"},{"key":"4516_CR21","doi-asserted-by":"publisher","unstructured":"Terg R, Casciato P, Garbe C, Cartier M, Stieben T, Mendizabal M, et al. Proton pump inhibitor therapy does not increase the incidence of spontaneous bacterial peritonitis in cirrhosis: a multicenter prospective study. J Hepatol. 2015;62(5):1056\u201360. https:\/\/doi.org\/10.1016\/j.jhep.2014.11.036.","DOI":"10.1016\/j.jhep.2014.11.036"},{"key":"4516_CR22","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1016\/j.dld.2015.12.009","volume":"48","author":"T Yu","year":"2016","unstructured":"Yu T, Tang Y, Jiang L, Zheng Y, Xiong W, Lin L. Proton pump inhibitor therapy and its association with spontaneous bacterial peritonitis incidence and mortality: a meta-analysis. Dig Liver Dis. 2016;48:353.","journal-title":"Dig Liver Dis"},{"issue":"4","key":"4516_CR23","doi-asserted-by":"publisher","first-page":"210","DOI":"10.2478\/jtim-2020-0034","volume":"8","author":"Lorenzo Ridola","year":"2020","unstructured":"Ridola Lorenzo, Faccioli Jessica, Nardelli Silvia, Gioia Stefania, Riggio Oliviero. Hepatic encephalopathy: diagnosis and management. J Transl Intern Med. 2020;8(4):210\u20139. https:\/\/doi.org\/10.2478\/jtim-2020-0034.","journal-title":"J Transl Intern Med"},{"issue":"21","key":"4516_CR24","doi-asserted-by":"publisher","first-page":"2683","DOI":"10.3748\/wjg.v25.i21.2683","volume":"25","author":"XX Tantai","year":"2019","unstructured":"Tantai XX, Yang LB, Wei ZC, Xiao CL, Chen LR, Wang JH, et al. Association of proton pump inhibitors with risk of hepatic encephalopathy in advanced liver disease: a meta-analysis. World J Gastroenterol. 2019;25(21):2683\u201398. https:\/\/doi.org\/10.3748\/wjg.v25.i21.2683.","journal-title":"World J Gastroenterol"},{"issue":"6","key":"4516_CR25","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1002\/cld.678","volume":"10","author":"DK Li","year":"2018","unstructured":"Li DK, Chung RT. Use of proton pump inhibitors in chronic liver diseases. Clin Liver Dis. 2018;10(6):148\u201351. https:\/\/doi.org\/10.1002\/cld.678.","journal-title":"Clin Liver Dis"},{"key":"4516_CR26","doi-asserted-by":"publisher","first-page":"1213","DOI":"10.1111\/apt.1382","volume":"44","author":"HL Cole","year":"2016","unstructured":"Cole HL, Pennycook S, Hayes PC. The impact of proton pump inhibitor therapy on patients with liver disease. Aliment Pharmacol Ther. 2016;44:1213\u201323. https:\/\/doi.org\/10.1111\/apt.1382.","journal-title":"Aliment Pharmacol Ther"},{"key":"4516_CR27","doi-asserted-by":"publisher","DOI":"10.1042\/BSR20193890","volume":"40","author":"W Xiaoli","year":"2020","unstructured":"Xiaoli W, Daofu Z, Yuexiao Y, Lianqing L, Xiaofei L. Proton pump inhibitor use and mortality in patients with cirrhosis: a meta-analysis of cohort studies. Biosci Rep. 2020;40:BSR20193890. https:\/\/doi.org\/10.1042\/BSR20193890.","journal-title":"Biosci Rep"}],"container-title":["BMC Gastroenterology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12876-025-04516-4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12876-025-04516-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12876-025-04516-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,4]],"date-time":"2026-02-04T11:16:24Z","timestamp":1770203784000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12876-025-04516-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,7]]},"references-count":27,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["4516"],"URL":"https:\/\/doi.org\/10.1186\/s12876-025-04516-4","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-7519036\/v1","asserted-by":"object"}]},"ISSN":["1471-230X"],"issn-type":[{"value":"1471-230X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,7]]},"assertion":[{"value":"2 September 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 November 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 January 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Our study adhered to the Declaration of Helsinki. Informed consent form was obtained from all participants. The study was deemed appropriate by the Recep Tayyip Erdogan University Faculty of Medicine Non-Interventional Clinical Research Ethics Committee with the decision numbered E- 40465587-050.01.04-493 dated 29.09.2022 and ethics committee approval was obtained with decision number 2022\/171.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not Applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"96"}}